South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome
August 1, 2025: People Who Experienced Vision Loss from Trulicity May Have New Legal Options Trulicity and other GLP-1 drugs can put people at an increased risk of a serious eye condition called NAION (non-arteritic anterior ischemic optic neuropathy), which can cause permanent blindness
3,4 GLP-1RAs mimic the action of endogenous GLP-1, activating GLP-1R, thereby enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and reducing food intake through central appetite suppression
The most common ones include nausea and diarrhea, especially when starting the medication
And for a while he thought everything was OK, right